This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability
New England Journal of Medicine · 2019
Latest funding
- $20,000
PECAN - Pulmonary Embolism Canada
CIHR · 2024 · Principal investigator
- $634,951
COBRRA trial: Comparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism
CIHR · 2023 · Co-investigator
- $382,500
High-dose cephalexin for cellulitis (HI-DOCC): a randomized controlled trial
CIHR · 2023 · Co-investigator
1 publications.
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability
Wu C, Kearon C, Hirsch A, Sharma S, Rudd-Scott L, Bates SM, de Wit K, Parpia S, Schulman S, Afilalo M
PECAN - Pulmonary Embolism Canada
Principal investigators: Castellucci, Lana; de Wit, Kerstin; Mendelson, Asher A
Keywords: Pulmonary Embolism
COBRRA trial: Comparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism
Principal investigators: Castellucci, Lana
Keywords: Anticoagulation; Bleeding Risk; Venous Thromboembolism
High-dose cephalexin for cellulitis (HI-DOCC): a randomized controlled trial
Principal investigators: Yadav, Krishan; Eagles, Debra; Emond, Marcel; Perry, Jeffrey J; Stiell, Ian G; Taljaard, Monica
Keywords: Antibiotics; Cellulitis; Treatment Failure
Comparison of Bleeding Risk between Rivaroxaban and Apixaban in Atrial Fibrillation (COBRRA AF)
Principal investigators: Castellucci, Lana; de Wit, Kerstin; Le Gal, Grégoire; Parkash, Ratika
Keywords: Atrial Fibrillation, Bleeding, Anticoagulation
Comparison of Bleeding Risk between Rivaroxaban and Apixaban in Atrial Fibrillation (COBRRA AF)
Principal investigators: Castellucci, Lana; de Wit, Kerstin; Le Gal, Grégoire; Perry, Jeffrey J
Keywords: Atrial Fibrillation, Bleeding, Anticoagulation
Safely Ruling out Deep Vein Thrombosis in Pregnancy with the LEFt Clinical Decision Rule and and D-dimer (the LEaD study): A Prospective Cohort Study
Principal investigators: Rodger, Marc A
Keywords: Clinical Decision Rule; D-Dimer; Deep Vein Thrombosis; Diagnosis; Pregnancy
Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial
Principal investigators: Castellucci, Lana; Rodger, Marc A
Keywords: Anticoagulation; Bleeding Risk; Venous Thromboembolism
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Department of Epidemiology and Biostatistics
- Department of Medicine
- Cardiology & Clinical Epidemiology
- Oncology
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Alejandro Lazo-Langner
Department of Epidemiology and Biostatistics
1 shared papers, latest 2019
Sameer Parpia
Oncology
1 shared papers, latest 2019
Frederick Spencer
Medicine
1 shared papers, latest 2019
Sam Schulman
Medicine
1 shared papers, latest 2019
Shannon Bates
Medicine
1 shared papers, latest 2019
Vinai Bhagirath
Medicine
1 shared papers, latest 2019
Kerstin de Wit
Medicine
1 shared papers, latest 2019
Sangita Sharma
Medicine
1 shared papers, latest 2019
Grégoire Le Gal
Department of Medicine
1 shared papers, latest 2019
Marc Afilalo
Cardiology & Clinical Epidemiology
1 shared papers, latest 2019
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.